Biopharmaceuticals – University of Copenhagen

With cutting-edge chemical biology approaches we aim to create peptides and proteins with novel properties in order to develop advanced protein-based drug candidates.

The Center for Biopharmaceuticals builds on the strong multidisciplinary relationship between the Department of Drug Design and Pharmacology and the Department of Pharmacy – the two pharmaceutical departments within the Faculty of Health and Medical Sciences. The Center opened on 1 January 2014 and has received a 'beacon' grant of 35 million DKK from the University of Copenhagen over the next five years for studies in protein medicinal chemistry.

Olsen lab

We use chemical entities to explore biology. Our current interests include novel peptido-mimetic foldamers, macrocyclic HDAC inhibitors and quorum sensing modulators, as well as lysine deacylase substrate specificity.


Pless lab

Using a combination of synthetic amino acids and spectroscopic approaches, we focus on the function and pharmacology of a therapeutically relevant class of membrane proteins called ion channels.



Strømgaard lab

We combine chemistry and biology to study therapeutically relevant proteins. This entails developing inhibitors of protein–protein interactions and studying proteins using semi-synthesis and unnatural mutagenesis.


News

Read all

Calendar

10 January 2018
CBP Advisory Board Meeting

16 January 2018
PhD Defense, Nima Rajabi (Olsen Lab)

18-19 January 2018
CBP Annual Retreat

25 January 2018
CBP Lecture, Professor David Craik, Uni. of Queensland, 11:00, Benzon Aud.

25 January 2018
PhD Defense, Iacopo Galliano (Olsen Lab)

Calendar Archives